News

And better still, healthy and growing dividend-paying stocks tend to increase their payouts over time. Pfizer's total annual ...
The tariff threat come just a few days after the White House sent letters to major drugmakers demanding slashed prices for US ...
Investor sentiment has been adversely affected by worries regarding the company’s drug pipeline. Nonetheless, we believe PFE ...
Pfizer beats Q2 2025 estimates, raises EPS guidance, boasts a 7%+ dividend yield, yet faces patent and pricing risks. See why ...
Shares in the data-software company were up 7.8% Tuesday after it posted higher quarterly results and [boosted its annual ...
Pfizer's Albert Bourla told investors that major drugmakers are "ready to to roll up their sleeves" and build out more direct ...
Pfizer CEO Albert Bourla is expected at a pro-Trump fundraiser on Friday, sources told CBS News, one day after the president ...
In the second quarter, Pfizer reported adjusted diluted earnings per share of $0.78 on revenue of nearly $14.7 billion. Both ...
Vietnam Investment Review on MSN2h
Pfizer Romania Named Best Place to Work for 2025
86% align with Pfizer's commitment to social responsibility 83% rate HR practices as people-focused 94% alignment with best ...
Pfizer (NYSE:PFE) develops and sells biopharmaceutical products, including vaccines, treatments for infectious diseases, ...